Porcine Epidemic Diarrhea Vaccines Global Market Report 2025

Description

Porcine epidemic diarrhea (PED) vaccines are formulated to confer immunity against the porcine epidemic diarrhea virus (PEDV), which causes severe gastrointestinal illness in pigs. These vaccines play a crucial role in preventing and managing outbreaks of Porcine Epidemic Diarrhea, thereby safeguarding the health and productivity of pig populations and ensuring the economic stability of the swine industry.

The primary types of porcine epidemic diarrhea vaccines are live vaccines and killed vaccines. Live vaccines contain attenuated or weakened forms of the PEDV virus. They are utilized in diverse settings, including piglets and adult pigs, across veterinary hospitals and hog production farms.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The porcine epidemic diarrhea vaccines market research report is one of a series of new reports from The Business Research Company that provides porcine epidemic diarrhea vaccines market statistics, including porcine epidemic diarrhea vaccines industry global market size, regional shares, competitors with a porcine epidemic diarrhea vaccines market share, detailed porcine epidemic diarrhea vaccines market segments, market trends, and opportunities, and any further data you may need to thrive in the porcine epidemic diarrhea vaccines industry. This porcine epidemic diarrhea vaccines research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The porcine epidemic diarrhea vaccines market size has grown strongly in recent years. It will grow from $1.67 billion in 2024 to $1.8 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to large-scale vaccination campaigns, expanded programs on immunization (EPI), the adoption of disposable syringes, diarrhea eradication efforts, and initiatives like the global alliance for vaccines and immunization (GAVI).

The porcine epidemic diarrhea vaccines market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to the growing emphasis on immunization programs, expanded vaccine development pipelines, expanding pig populations, focus on cold chain management, and rising awareness about the importance of preventive healthcare measures. Major trends in the forecast period include continued innovations in vaccine delivery device technology, focus on needle-free solutions, advancements in personalized medicine, growing preference for self-administered vaccines, and strengthening animal healthcare infrastructure and distribution networks.

The forecast of 7.1% growth over the next five years remains unchanged from the previous projection for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. livestock producers by inflating prices of swine coronavirus vaccine strains and oral herd immunization systems developed in the Netherlands and South Korea, resulting in delayed outbreak containment and higher veterinary intervention costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the porcine epidemic diarrhea (PED) vaccine market is expected to be driven by the rising pig farming industry. Pig farming encompasses the raising of domestic pigs for meat production, breeding, rearing, managing them from birth to market weight, and marketing and selling pork products. The expansion of pig farming is fueled by the growing global demand for pork, improvements in breeding and management practices, advancements in farming technology, and the expanding markets for pork consumption. PED vaccines play a crucial role in preventing and managing outbreaks in pig farming. These vaccines are typically administered through injection or orally, starting during the sow's gestation period, to provide passive immunity to newborn piglets via colostrum. For example, the United States Department of Agriculture reported that in 2022, pork production in the U.S. reached 40.6 billion pounds, marking a 1 percent increase compared to the previous year. Consequently, the growth of pig farming is a key factor driving the demand for porcine epidemic diarrhea vaccines.

Leading companies in the porcine epidemic diarrhea vaccines sector are focusing on innovation to strengthen their market positions. One notable development is the introduction of the porcine parvovirus (PPV) vaccine, designed to prevent reproductive failures in pigs caused by PPV. Boehringer Ingelheim launched the ReproCyc ParvoFLEX vaccine in March 2022, which offers comprehensive protection against infertility, stillbirths, mummified fetuses, and weak piglets resulting from PPV. This innovative vaccine underscores the company's commitment to enhancing the health and productivity of pig herds through advanced formulation and efficacy.

In November 2024, Phibro Animal Health Corporation, a US-based health company, acquired Zoetis Inc. for an undisclosed amount. This acquisition is intended to expand Phibro's product offerings in medicated feed additives and water-soluble products for cattle, swine, and poultry, enhancing its ability to support global animal health and nutrition. Additionally, the acquisition aims to boost Phibro's profitability, grow its revenue base, and provide capital for future investments in the animal health sector. Zoetis Inc. is a pharmaceutical manufacturer specializing in the production of vaccines for porcine epidemic diarrhea.

Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Sante Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd., IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saude Animal, Medgene Labs, Harrisvaccines Inc

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the porcine epidemic diarrhea vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The porcine epidemic diarrhea vaccines market consists of sales of ingelvac PEDV, barricade, PED vax, PEDV shield, and enterisol ileitis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Porcine Epidemic Diarrhea Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on porcine epidemic diarrhea vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for porcine epidemic diarrhea vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The porcine epidemic diarrhea vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Live Vaccines; Killed Vaccines
2) By Application: Piglets; Adults Pigs
3) By End-User: Veterinary Hospitals; Hog Production Farms
Subsegments:
1) By Live Vaccines: Oral Live Vaccines; Injectable Live Vaccines
2) By Killed Vaccines: Inactivated Injectable Vaccines; Inactivated Oral Vaccines
Companies Mentioned: Zoetis Inc.; Merck Animal Health; Elanco Animal Health; Idexx Laboratories Inc.; Bio-Rad Laboratories Inc.; Ceva Sante Animale Health Company; Phibro Animal Health Corporation; Benchmark Animal Health Ltd.; IDT Biologika GmbH; Vaxxinova; Qilu Animal Health Products Factory Co. Ltd.; Tecnovax; Green Cross Veterinary Products Co. Ltd.; Nisseiken Co. Ltd.; Komipharm International Co. Ltd.; Boehringer Ingelheim Animal Health; MSD Animal Health; Ourofino Saude Animal; Medgene Labs; Harrisvaccines Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r30982u

1. Executive Summary

2. Porcine Epidemic Diarrhea Vaccines Market Characteristics

3. Porcine Epidemic Diarrhea Vaccines Market Trends And Strategies

4. Porcine Epidemic Diarrhea Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Porcine Epidemic Diarrhea Vaccines Growth Analysis And Strategic Analysis Framework

5.1. Global Porcine Epidemic Diarrhea Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Porcine Epidemic Diarrhea Vaccines Market Growth Rate Analysis
5.4. Global Porcine Epidemic Diarrhea Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Porcine Epidemic Diarrhea Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Porcine Epidemic Diarrhea Vaccines Total Addressable Market (TAM)

6. Porcine Epidemic Diarrhea Vaccines Market Segmentation

6.1. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Vaccines
Killed Vaccines
6.2. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Piglets
Adults Pigs
6.3. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Veterinary Hospitals
Hog Production Farms
6.4. Global Porcine Epidemic Diarrhea Vaccines Market, Sub-Segmentation Of Live Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Live Vaccines
Injectable Live Vaccines
6.5. Global Porcine Epidemic Diarrhea Vaccines Market, Sub-Segmentation Of Killed Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated Injectable Vaccines
Inactivated Oral Vaccines

7. Porcine Epidemic Diarrhea Vaccines Market Regional And Country Analysis

7.1. Global Porcine Epidemic Diarrhea Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Porcine Epidemic Diarrhea Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market

8.1. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Porcine Epidemic Diarrhea Vaccines Market

9.1. China Porcine Epidemic Diarrhea Vaccines Market Overview
9.2. China Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Porcine Epidemic Diarrhea Vaccines Market

10.1. India Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Porcine Epidemic Diarrhea Vaccines Market

11.1. Japan Porcine Epidemic Diarrhea Vaccines Market Overview
11.2. Japan Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Porcine Epidemic Diarrhea Vaccines Market

12.1. Australia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Porcine Epidemic Diarrhea Vaccines Market

13.1. Indonesia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Porcine Epidemic Diarrhea Vaccines Market

14.1. South Korea Porcine Epidemic Diarrhea Vaccines Market Overview
14.2. South Korea Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Porcine Epidemic Diarrhea Vaccines Market

15.1. Western Europe Porcine Epidemic Diarrhea Vaccines Market Overview
15.2. Western Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Porcine Epidemic Diarrhea Vaccines Market

16.1. UK Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Porcine Epidemic Diarrhea Vaccines Market

17.1. Germany Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Porcine Epidemic Diarrhea Vaccines Market

18.1. France Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Porcine Epidemic Diarrhea Vaccines Market

19.1. Italy Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Porcine Epidemic Diarrhea Vaccines Market

20.1. Spain Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market

21.1. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market Overview
21.2. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Porcine Epidemic Diarrhea Vaccines Market

22.1. Russia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Porcine Epidemic Diarrhea Vaccines Market

23.1. North America Porcine Epidemic Diarrhea Vaccines Market Overview
23.2. North America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Porcine Epidemic Diarrhea Vaccines Market

24.1. USA Porcine Epidemic Diarrhea Vaccines Market Overview
24.2. USA Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Porcine Epidemic Diarrhea Vaccines Market

25.1. Canada Porcine Epidemic Diarrhea Vaccines Market Overview
25.2. Canada Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Porcine Epidemic Diarrhea Vaccines Market

26.1. South America Porcine Epidemic Diarrhea Vaccines Market Overview
26.2. South America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Porcine Epidemic Diarrhea Vaccines Market

27.1. Brazil Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Porcine Epidemic Diarrhea Vaccines Market

28.1. Middle East Porcine Epidemic Diarrhea Vaccines Market Overview
28.2. Middle East Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Porcine Epidemic Diarrhea Vaccines Market

29.1. Africa Porcine Epidemic Diarrhea Vaccines Market Overview
29.2. Africa Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Porcine Epidemic Diarrhea Vaccines Market Competitive Landscape And Company Profiles

30.1. Porcine Epidemic Diarrhea Vaccines Market Competitive Landscape
30.2. Porcine Epidemic Diarrhea Vaccines Market Company Profiles
- 30.2.1. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck Animal Health Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Elanco Animal Health Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Idexx Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Porcine Epidemic Diarrhea Vaccines Market Other Major And Innovative Companies

31.1. Ceva Sante Animale Health Company
31.2. Phibro Animal Health Corporation
31.3. Benchmark Animal Health Ltd.
31.4. IDT Biologika GmbH
31.5. Vaxxinova
31.6. Qilu Animal Health Products Factory Co. Ltd.
31.7. Tecnovax
31.8. Green Cross Veterinary Products Co. Ltd.
31.9. Nisseiken Co. Ltd.
31.10. Komipharm International Co. Ltd.
31.11. Boehringer Ingelheim Animal Health
31.12. MSD Animal Health
31.13. Ourofino Saude Animal
31.14. Medgene Labs
31.15. Harrisvaccines Inc

32. Global Porcine Epidemic Diarrhea Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Porcine Epidemic Diarrhea Vaccines Market

34. Recent Developments In The Porcine Epidemic Diarrhea Vaccines Market

35. Porcine Epidemic Diarrhea Vaccines Market High Potential Countries, Segments and Strategies

35.1 Porcine Epidemic Diarrhea Vaccines Market In 2029 - Countries Offering Most New Opportunities
35.2 Porcine Epidemic Diarrhea Vaccines Market In 2029 - Segments Offering Most New Opportunities
35.3 Porcine Epidemic Diarrhea Vaccines Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer